FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040631907> ?p ?o ?g. }

• W2040631907 endingPage "1800" @default.
• W2040631907 startingPage "1795" @default.
• W2040631907 abstract "Objectives: To evaluate pharmacokinetics of nevirapine, lamivudine and stavudine in HIV-infected Zambian infants receiving fixed dose combination (FDC) antiretroviral tablets (Triomune Baby). Design: Phase I/II study. Methods: Sixteen HIV-infected children at least 1 month, weighing 3 kg to less than 6 kg were enrolled. Blood was sampled at t = 0, 2, 6 and 12 h after observed intake of one FDC tablet (50 mg nevirapine, 6 mg stavudine, 30 mg lamivudine) 4 weeks after starting treatment. Safety and viral load response over 48 weeks were determined. Results: The median [interquartile range (IQR)] age, body weight and daily nevirapine dose in 15 included children (eight girls) were 4.8 (4.2, 8.4) months, 5.3 (4.3, 5.5) kg and 348 (326 385) mg/m2, respectively. The median (IQR) nevirapine area under the concentration–time curve (AUC0–12 h), Cmax and C12 h were 70 (56, 104) h mg/l, 7.5 (6.2, 10) mg/l, and 4.3 (2.9, 6.9) mg/l, respectively. Values were on average higher than reported in adults, but approximately 20% lower than previously reported in children weighing at least 6 kg. Four of 15 (27%) children had a subtherapeutic nevirapine C12 h (defined as <3.0 mg/l) compared to only three of 63 (5%) children weighing at least 6 kg (P = 0.02), whereas children aged less than 5 months [three of six (50%)] may have the highest risk for subtherapeutic nevirapine C12 h (P = 0.24). No association was found between viral load values and nevirapine plasma pharmacokinetic parameters (P > 0.3). Stavudine–lamivudine pharmacokinetic parameters were broadly comparable to heavier children. Conclusion: Exposure to nevirapine in African, HIV-infected infants with low body weight taking FDC tablets appears on average to be adequate, but due to large intersubject variability a relatively high proportion had subtherapeutic nevirapine C12 h levels, particularly those aged less than 5 months." @default.
• W2040631907 created "2016-06-24" @default.
• W2040631907 creator A5008600922 @default.
• W2040631907 creator A5015650116 @default.
• W2040631907 creator A5021568119 @default.
• W2040631907 creator A5030902925 @default.
• W2040631907 creator A5039928708 @default.
• W2040631907 creator A5044933203 @default.
• W2040631907 creator A5052674918 @default.
• W2040631907 creator A5053995084 @default.
• W2040631907 creator A5073473981 @default.
• W2040631907 creator A5075583752 @default.
• W2040631907 creator A5083684284 @default.
• W2040631907 date "2012-09-10" @default.
• W2040631907 modified "2023-09-26" @default.
• W2040631907 title "Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets" @default.
• W2040631907 cites W1981476848 @default.
• W2040631907 cites W1981712752 @default.
• W2040631907 cites W2004074158 @default.
• W2040631907 cites W2013907757 @default.
• W2040631907 cites W2028921104 @default.
• W2040631907 cites W2035412462 @default.
• W2040631907 cites W2036611705 @default.
• W2040631907 cites W2068559235 @default.
• W2040631907 cites W2097679411 @default.
• W2040631907 cites W2100906729 @default.
• W2040631907 cites W2115153490 @default.
• W2040631907 cites W2116896319 @default.
• W2040631907 cites W2123211579 @default.
• W2040631907 cites W2123723435 @default.
• W2040631907 cites W2124543441 @default.
• W2040631907 cites W2145341868 @default.
• W2040631907 cites W2160213066 @default.
• W2040631907 cites W2170003531 @default.
• W2040631907 cites W4239963138 @default.
• W2040631907 cites W4321429248 @default.
• W2040631907 doi "https://doi.org/10.1097/qad.0b013e32835705fd" @default.
• W2040631907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22739394" @default.
• W2040631907 hasPublicationYear "2012" @default.
• W2040631907 type Work @default.
• W2040631907 sameAs 2040631907 @default.
• W2040631907 citedByCount "16" @default.
• W2040631907 countsByYear W20406319072013 @default.
• W2040631907 countsByYear W20406319072014 @default.
• W2040631907 countsByYear W20406319072015 @default.
• W2040631907 countsByYear W20406319072016 @default.
• W2040631907 countsByYear W20406319072017 @default.
• W2040631907 countsByYear W20406319072018 @default.
• W2040631907 countsByYear W20406319072020 @default.
• W2040631907 countsByYear W20406319072021 @default.
• W2040631907 crossrefType "journal-article" @default.
• W2040631907 hasAuthorship W2040631907A5008600922 @default.
• W2040631907 hasAuthorship W2040631907A5015650116 @default.
• W2040631907 hasAuthorship W2040631907A5021568119 @default.
• W2040631907 hasAuthorship W2040631907A5030902925 @default.
• W2040631907 hasAuthorship W2040631907A5039928708 @default.
• W2040631907 hasAuthorship W2040631907A5044933203 @default.
• W2040631907 hasAuthorship W2040631907A5052674918 @default.
• W2040631907 hasAuthorship W2040631907A5053995084 @default.
• W2040631907 hasAuthorship W2040631907A5073473981 @default.
• W2040631907 hasAuthorship W2040631907A5075583752 @default.
• W2040631907 hasAuthorship W2040631907A5083684284 @default.
• W2040631907 hasBestOaLocation W20406319071 @default.
• W2040631907 hasConcept C112705442 @default.
• W2040631907 hasConcept C119060515 @default.
• W2040631907 hasConcept C126322002 @default.
• W2040631907 hasConcept C142462285 @default.
• W2040631907 hasConcept C203014093 @default.
• W2040631907 hasConcept C22979827 @default.
• W2040631907 hasConcept C2522874641 @default.
• W2040631907 hasConcept C2776623344 @default.
• W2040631907 hasConcept C2777869810 @default.
• W2040631907 hasConcept C2779130552 @default.
• W2040631907 hasConcept C2779889181 @default.
• W2040631907 hasConcept C2780593183 @default.
• W2040631907 hasConcept C2993143319 @default.
• W2040631907 hasConcept C3013748606 @default.
• W2040631907 hasConcept C71924100 @default.
• W2040631907 hasConcept C90924648 @default.
• W2040631907 hasConceptScore W2040631907C112705442 @default.
• W2040631907 hasConceptScore W2040631907C119060515 @default.
• W2040631907 hasConceptScore W2040631907C126322002 @default.
• W2040631907 hasConceptScore W2040631907C142462285 @default.
• W2040631907 hasConceptScore W2040631907C203014093 @default.
• W2040631907 hasConceptScore W2040631907C22979827 @default.
• W2040631907 hasConceptScore W2040631907C2522874641 @default.
• W2040631907 hasConceptScore W2040631907C2776623344 @default.
• W2040631907 hasConceptScore W2040631907C2777869810 @default.
• W2040631907 hasConceptScore W2040631907C2779130552 @default.
• W2040631907 hasConceptScore W2040631907C2779889181 @default.
• W2040631907 hasConceptScore W2040631907C2780593183 @default.
• W2040631907 hasConceptScore W2040631907C2993143319 @default.
• W2040631907 hasConceptScore W2040631907C3013748606 @default.
• W2040631907 hasConceptScore W2040631907C71924100 @default.
• W2040631907 hasConceptScore W2040631907C90924648 @default.
• W2040631907 hasIssue "14" @default.
• W2040631907 hasLocation W20406319071 @default.
• W2040631907 hasLocation W20406319072 @default.

• next